Pancreatic Cancer Research
Dr Angela Alistar
Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the Phase I Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology. Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials. Dr. Alistar comes to Atlantic Health from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research… Read More (Source: Atlantic Health)
Dr Daniel Von Hoff
The Jo-Ann Danzis Foundation sponsored a lecture given by the world renowned pancreatic cancer research leader, Daniel D. Von Hoff, M.D. in October, 2018. The lecture, held at Morristown Medical Center, provided information on his groundbreaking research on the investigational use of anti-cancer compounds and phase I clinical trial data at Atlantic Health System’s Morristown Medical Center. Dr. Von Hoff is Physician-in-Chief and Distinguished Professor at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona.
Introduced by physician researcher and medical director of GI medical oncology at Morristown Medical Center, Dr. Angela Alistar remarked, “Dr. Von Hoff is the most accomplished scientist in my world.”
Dr. Von Hoff’s lecture, “Improving Survival for Patients with Stage IV Pancreatic Cancer,” was the inaugural research lecture of the Breakthrough Oncology Accelerator…Today’s lecture was sponsored by the Jo-Ann Danzis Foundation. (Source: Tap Into Morristown)